Detailed information for compound 510324

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 407.357 | Formula: C20H20Cl2N2OS
  • H donors: 1 H acceptors: 2 LogP: 6.39 Rotable bonds: 4
    Rule of 5 violations (Lipinski): 1
  • SMILES: Clc1ccc(cc1)C[S+](c1cc2nc([nH]c2cc1Cl)C1CCCCC1)[O-]
  • InChi: 1S/C20H20Cl2N2OS/c21-15-8-6-13(7-9-15)12-26(25)19-11-18-17(10-16(19)22)23-20(24-18)14-4-2-1-3-5-14/h6-11,14H,1-5,12H2,(H,23,24)
  • InChiKey: YOKLQOQVQYIXAR-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens cannabinoid receptor 2 (macrophage) Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Schistosoma mansoni DNA topoisomerase type I 0.021 0.2512 0.236
Trichomonas vaginalis fructose-bisphosphate aldolase, putative 0.033 0.4095 1
Trypanosoma brucei DNA polymerase IV, putative 0.0046 0.036 0.085
Trypanosoma brucei DNA polymerase kappa, putative 0.0046 0.036 0.085
Brugia malayi hypothetical protein 0.0184 0.2179 0.748
Plasmodium vivax thioredoxin reductase, putative 0.0043 0.0318 0.0512
Trichomonas vaginalis ral, putative 0.0064 0.0594 0.0626
Trypanosoma cruzi DNA topoisomerase type IB small subunit, putative 0.0053 0.0448 0.0334
Trypanosoma brucei DNA polymerase kappa, putative 0.0035 0.0213 0.0504
Trichomonas vaginalis rheb, putative 0.0064 0.0594 0.0626
Mycobacterium tuberculosis Conserved hypothetical protein 0.018 0.2118 1
Trypanosoma cruzi mitochondrial DNA polymerase beta-PAK, putative 0.0048 0.0386 0.0176
Echinococcus multilocularis thioredoxin glutathione reductase 0.0043 0.0325 0.0128
Trypanosoma brucei DNA polymerase kappa, putative 0.0046 0.036 0.085
Trypanosoma brucei DNA polymerase kappa, putative 0.0035 0.0213 0.0504
Entamoeba histolytica fructose-1,6-bisphosphate aldolase, putative 0.033 0.4095 1
Trypanosoma brucei DNA polymerase kappa, putative 0.0046 0.036 0.085
Plasmodium falciparum topoisomerase I 0.021 0.2512 1
Onchocerca volvulus 0.0041 0.029 0.0297
Mycobacterium ulcerans DNA polymerase IV 0.0046 0.036 0.0383
Echinococcus multilocularis transfer RNA-Lys 0.0041 0.029 0.0093
Brugia malayi Thioredoxin reductase 0.0043 0.0318 0.0447
Mycobacterium ulcerans DNA polymerase IV 0.0046 0.036 0.0383
Trypanosoma brucei DNA topoisomerase type IB small subunit 0.0053 0.0448 0.1058
Mycobacterium tuberculosis Probable NADH dehydrogenase Ndh 0.0098 0.1037 0.4732
Brugia malayi PAS domain containing protein 0.0055 0.0478 0.1054
Schistosoma mansoni DNA topoisomerase type I 0.0157 0.1819 0.1653
Plasmodium vivax glutathione reductase, putative 0.0043 0.0318 0.0512
Leishmania major DNA topoisomerase IB, large subunit 0.0157 0.1819 0.4201
Brugia malayi Ras-related protein R-Ras2 0.0064 0.0594 0.1493
Giardia lamblia Fructose-bisphosphate aldolase 0.033 0.4095 1
Plasmodium vivax topoisomerase I, putative 0.021 0.2512 1
Trichomonas vaginalis set domain proteins, putative 0.0268 0.3272 0.7798
Brugia malayi polk-prov protein 0.0035 0.0213 0.0054
Trypanosoma brucei DNA topoisomerase IB, large subunit 0.0157 0.1819 0.4292
Brugia malayi bHLH-PAS transcription factor 0.0041 0.029 0.0345
Trichomonas vaginalis ras-dva small GTPase, putative 0.0064 0.0594 0.0626
Echinococcus multilocularis ras gtpase 0.0064 0.0594 0.0403
Mycobacterium tuberculosis Probable membrane NADH dehydrogenase NdhA 0.0098 0.1037 0.4732
Trypanosoma cruzi DNA polymerase kappa, putative 0.0046 0.036 0.0109
Leishmania major mitochondrial DNA polymerase beta-PAK, putative 0.0162 0.1878 0.4341
Loa Loa (eye worm) pre-SET domain-containing protein family protein 0.0235 0.2845 1
Mycobacterium tuberculosis Probable fructose-bisphosphate aldolase Fba 0.0161 0.1875 0.882
Trypanosoma cruzi DNA polymerase beta thumb, putative 0.0048 0.0386 0.0176
Echinococcus granulosus DNA topoisomerase 1 0.021 0.2512 0.2372
Brugia malayi Pre-SET motif family protein 0.0235 0.2845 1
Echinococcus granulosus ras gtpase 0.0064 0.0594 0.0419
Echinococcus granulosus thioredoxin glutathione reductase 0.0043 0.0325 0.0145
Trypanosoma cruzi mitochondrial DNA polymerase beta-PAK, putative 0.0162 0.1878 0.3978
Echinococcus multilocularis microtubule associated protein 2 0.078 1 1
Trypanosoma brucei DNA polymerase kappa, putative 0.0024 0.0066 0.0156
Trypanosoma brucei trypanothione reductase 0.0043 0.0318 0.0749
Trypanosoma cruzi mitochondrial DNA polymerase beta, putative 0.0341 0.4239 1
Trypanosoma brucei DNA polymerase kappa, putative 0.0046 0.036 0.085
Trichomonas vaginalis dexras1, putative 0.0064 0.0594 0.0626
Loa Loa (eye worm) Ras protein let-60 0.0064 0.0594 0.1493
Mycobacterium leprae Probable fructose bisphosphate aldolase Fba 0.0161 0.1875 1
Trypanosoma brucei DNA polymerase kappa, putative 0.0046 0.036 0.085
Mycobacterium tuberculosis Probable reductase 0.0098 0.1037 0.4732
Echinococcus granulosus histone lysine methyltransferase setb 0.0034 0.0199 0.0017
Treponema pallidum fructose-bisphosphate aldolase 0.033 0.4095 0.5
Brugia malayi Ras protein let-60 0.0064 0.0594 0.1493
Trypanosoma cruzi DNA polymerase kappa, putative 0.0046 0.036 0.0109
Mycobacterium tuberculosis Putative ferredoxin reductase 0.0098 0.1037 0.4732
Trypanosoma brucei DNA polymerase kappa, putative 0.0046 0.036 0.085
Mycobacterium tuberculosis Probable oxidoreductase 0.0108 0.118 0.5429
Trichomonas vaginalis fructose-bisphosphate aldolase, putative 0.033 0.4095 1
Trichomonas vaginalis fructose-bisphosphate aldolase, putative 0.033 0.4095 1
Toxoplasma gondii DNA topoisomerase I, putative 0.021 0.2512 1
Trypanosoma brucei DNA polymerase kappa, putative 0.0046 0.036 0.085
Mycobacterium tuberculosis NAD(P)H quinone reductase LpdA 0.0108 0.118 0.5429
Mycobacterium tuberculosis Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB 0.0098 0.1037 0.4732
Schistosoma mansoni aryl hydrocarbon receptor 0.0055 0.0478 0.0285
Trypanosoma brucei unspecified product 0.0039 0.0263 0.0621
Trypanosoma brucei DNA polymerase kappa, putative 0.0046 0.036 0.085
Mycobacterium ulcerans hypothetical protein 0.018 0.2118 1
Leishmania major trypanothione reductase 0.0043 0.0318 0.0602
Mycobacterium leprae DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE 0.0108 0.118 0.1705
Trypanosoma brucei DNA polymerase beta thumb, putative 0.0048 0.0386 0.0911
Onchocerca volvulus 0.0268 0.3272 1
Schistosoma mansoni single-minded 0.0055 0.0478 0.0285
Echinococcus granulosus dna polymerase kappa 0.0046 0.036 0.0181
Mycobacterium ulcerans fructose-bisphosphate aldolase 0.0161 0.1875 0.8675
Entamoeba histolytica fructose-1,6-bisphosphate aldolase, putative 0.033 0.4095 1
Loa Loa (eye worm) glutathione reductase 0.0043 0.0318 0.0447
Trypanosoma cruzi DNA polymerase beta thumb, putative 0.0048 0.0386 0.0176
Echinococcus multilocularis dna polymerase kappa 0.0046 0.036 0.0165
Loa Loa (eye worm) DNA topoisomerase I 0.021 0.2512 0.874
Trichomonas vaginalis fructose-bisphosphate aldolase, putative 0.033 0.4095 1
Trypanosoma brucei mitochondrial DNA polymerase beta-PAK 0.0162 0.1878 0.4429
Loa Loa (eye worm) hypothetical protein 0.0064 0.0594 0.1493
Mycobacterium tuberculosis NADPH-dependent mycothiol reductase Mtr 0.0043 0.0318 0.1226
Trypanosoma brucei mitochondrial DNA polymerase beta 0.0341 0.4239 1
Trypanosoma cruzi DNA polymerase kappa, putative 0.0046 0.036 0.0109
Brugia malayi hypoxia-induced factor 1 0.017 0.1991 0.6771
Schistosoma mansoni DNA topoisomerase type I 0.0157 0.1819 0.1653
Trypanosoma cruzi DNA polymerase kappa, putative 0.0046 0.036 0.0109
Loa Loa (eye worm) hypoxia-induced factor 1 0.017 0.1991 0.6771
Trypanosoma brucei DNA polymerase kappa, putative 0.0046 0.036 0.085
Brugia malayi DNA topoisomerase I 0.021 0.2512 0.874
Leishmania major mitochondrial DNA polymerase beta 0.0341 0.4239 1
Brugia malayi glutathione reductase 0.0043 0.0318 0.0447
Leishmania major DNA topoisomerase type IB small subunit 0.0053 0.0448 0.0916
Trypanosoma cruzi DNA topoisomerase IB, large subunit, putative 0.0157 0.1819 0.383
Trichomonas vaginalis GTP-binding protein rit, putative 0.0064 0.0594 0.0626
Trypanosoma cruzi mitochondrial DNA polymerase beta-PAK, putative 0.0058 0.0524 0.0527
Trypanosoma brucei DNA polymerase IV, putative 0.0046 0.036 0.085
Loa Loa (eye worm) hypothetical protein 0.0184 0.2179 0.748
Toxoplasma gondii hypothetical protein 0.0055 0.0479 0.1211
Trypanosoma brucei DNA polymerase IV, putative 0.0039 0.0263 0.0621
Schistosoma mansoni microtubule-associated protein tau 0.078 1 1
Mycobacterium tuberculosis Probable dehydrogenase 0.0098 0.1037 0.4732
Trichomonas vaginalis fructose-bisphosphate aldolase, putative 0.033 0.4095 1
Trypanosoma cruzi mitochondrial DNA polymerase beta, putative 0.0341 0.4239 1
Trichomonas vaginalis rap1 and, putative 0.0064 0.0594 0.0626
Toxoplasma gondii thioredoxin reductase 0.0043 0.0318 0.0512
Trichomonas vaginalis fructose-bisphosphate aldolase, putative 0.033 0.4095 1
Echinococcus multilocularis DNA topoisomerase 1 0.021 0.2512 0.236
Loa Loa (eye worm) hypothetical protein 0.0035 0.0213 0.0054
Loa Loa (eye worm) thioredoxin reductase 0.0043 0.0318 0.0447
Trichomonas vaginalis fructose-bisphosphate aldolase, putative 0.033 0.4095 1
Trichomonas vaginalis fructose-bisphosphate aldolase, putative 0.033 0.4095 1
Echinococcus granulosus single minded 2 0.0041 0.029 0.011
Mycobacterium tuberculosis Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras 0.0108 0.118 0.5429

Activities

Activity type Activity value Assay description Source Reference
EC50 (functional) < 1 nM Agonist activity at human CB2 receptor ChEMBL. 18394887
EC50 (functional) < 1 nM Agonist activity at human CB2 receptor ChEMBL. 18394887
Efficacy (functional) >= 100 % Agonist activity at human CB2 receptor ChEMBL. 18394887
Efficacy (functional) >= 100 % Agonist activity at human CB2 receptor ChEMBL. 18394887
Inhibition (ADMET) < 50 % Inhibition of CYP1A2 (unknown origin) ChEMBL. 18394887
Inhibition (ADMET) < 50 % Inhibition of CYP2C19 (unknown origin) ChEMBL. 18394887
Inhibition (ADMET) < 50 % Inhibition of CYP2C9 (unknown origin) ChEMBL. 18394887
Inhibition (ADMET) < 50 % Inhibition of CYP2D6 (unknown origin) ChEMBL. 18394887
Inhibition (ADMET) < 50 % Inhibition of CYP3A4 (unknown origin) ChEMBL. 18394887
Inhibition (ADMET) < 50 % Inhibition of CYP1A2 (unknown origin) ChEMBL. 18394887
Inhibition (ADMET) < 50 % Inhibition of CYP2C19 (unknown origin) ChEMBL. 18394887
Inhibition (ADMET) < 50 % Inhibition of CYP2C9 (unknown origin) ChEMBL. 18394887
Inhibition (ADMET) < 50 % Inhibition of CYP2D6 (unknown origin) ChEMBL. 18394887
Inhibition (ADMET) < 50 % Inhibition of CYP3A4 (unknown origin) ChEMBL. 18394887
Ratio EC50 (binding) > 1000 Ratio of EC50 for CB2 receptor (unknown origin) to EC50 for CB1 receptor (unknow origin) ChEMBL. 18394887
Solubility > 20 uM Solubility of the compound at pH 7.4 ChEMBL. 18394887
Solubility > 20 uM Solubility of the compound at pH 4 ChEMBL. 18394887
Stabilty (ADMET) < 50 % Metabolic stability in human liver microsomes after 15 mins ChEMBL. 18394887

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.